JP2007283132A - Liquid injection needle and liquid injector - Google Patents

Liquid injection needle and liquid injector Download PDF

Info

Publication number
JP2007283132A
JP2007283132A JP2007203468A JP2007203468A JP2007283132A JP 2007283132 A JP2007283132 A JP 2007283132A JP 2007203468 A JP2007203468 A JP 2007203468A JP 2007203468 A JP2007203468 A JP 2007203468A JP 2007283132 A JP2007283132 A JP 2007283132A
Authority
JP
Japan
Prior art keywords
needle
liquid
puncture
chemical
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007203468A
Other languages
Japanese (ja)
Inventor
Tetsuya Ooyanai
哲也 大谷内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP2007203468A priority Critical patent/JP2007283132A/en
Publication of JP2007283132A publication Critical patent/JP2007283132A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/329Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
    • A61M5/288Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened by piercing without internal pressure increase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/347Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a liquid injection needle which can reduces the pain given to a patient, can be easily manufactured, and whose needle part has a strength penetrating through a rubber plug and can reduce the injection resistance, and to provide a liquid injector. <P>SOLUTION: This chemical liquid injection needle 1 comprises a piercing needle part 2 having a piercing part 21 which can be pierced into a living body, a chemical liquid introducing needle part 3 communicable with the chemical liquid vessel inner part, and a housing 4 for supporting the needle parts 2 and 3 in the state where the chemical liquid can pass between the piercing needle part 2 and the chemical liquid introducing needle part 3. The chemical liquid introducing needle part 3 has an outer diameter larger than at least the vicinity of the tip of the piercing part 21 of the piercing needle part 2, and a cutting edge 31 is formed on the end part of the base end side of the chemical liquid introducing needle part 3. The piercing needle part and a liquid introducing needle part are formed with the same one needle body. The piercing needle part has a middle part formed between the piercing part and the liquid introducing needle part and connecting both the parts smoothly by continuously changing the outer diameter. The outer diameter of the piercing part is 0.1 mm or more and 0.254 mm or less, and the inner diameter of the piercing part is 0.05 mm or more and 0.15 mm or less. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、液体注入針および液体注入装置に関し、さらに詳しくは、例えば薬液などの液体を生体内に注入する際に用いられる液体注入針および液体注入装置に関する。   The present invention relates to a liquid injection needle and a liquid injection device, and more particularly to a liquid injection needle and a liquid injection device used when injecting a liquid such as a chemical into a living body.

従来、薬液を皮内、皮下、筋肉層などの生体内に注入する際に用いられる薬液注入針としては、例えば図17および図18に示す薬液注入針が知られている。   Conventionally, as a chemical solution injection needle used when a chemical solution is injected into a living body such as an intradermal, subcutaneous, or muscle layer, for example, the chemical solution injection needles shown in FIGS. 17 and 18 are known.

図示のように、薬液注入針101は、針部102と、針部102を支持する基体部104とを備えている。針部102は、一定の外径を有する中空針から構成されており、基体部104に固着されている。この針部102の基端側には、刃先131が形成されている。また、基体部104の内面には、取り付け用の雌ねじ143が形成されている。   As illustrated, the chemical injection needle 101 includes a needle portion 102 and a base portion 104 that supports the needle portion 102. The needle part 102 is composed of a hollow needle having a constant outer diameter, and is fixed to the base part 104. A blade edge 131 is formed on the proximal end side of the needle portion 102. Further, a female screw 143 for attachment is formed on the inner surface of the base portion 104.

薬液注入針101は、例えば市場に出回っているような、薬液が充填されている図示しない薬液容器の先端部に形成された薬液注入口に取り付けられる。薬液容器の薬液注入口には、雄ねじが形成されており、この雄ねじに、薬液注入針101の雌ねじ143が螺合されることにより、薬液注入針101の薬液容器への取り付けが行われる。   The chemical solution injection needle 101 is attached to a chemical solution injection port formed at the distal end portion of a chemical solution container (not shown) filled with a chemical solution, which is available on the market, for example. A male screw is formed in the chemical liquid injection port of the chemical liquid container, and the female screw 143 of the chemical liquid injection needle 101 is screwed into the male screw, whereby the chemical liquid injection needle 101 is attached to the chemical liquid container.

ここで、薬液容器の薬液注入口は、図示しないゴム栓により封止されている。薬液注入針101の薬液容器への取り付け時に、針部102の基端側に形成された刃先131が上記ゴム栓を貫くことにより、針部102内と薬液容器内とが連通されるようになっている。   Here, the chemical solution inlet of the chemical solution container is sealed with a rubber stopper (not shown). When the chemical injection needle 101 is attached to the chemical solution container, the blade tip 131 formed on the proximal end side of the needle portion 102 penetrates the rubber stopper, so that the inside of the needle portion 102 and the inside of the chemical solution container are communicated. ing.

しかしながら、上記した従来の薬液注入針101にあっては、針部102として、外径が0.25mmより大きい比較的太い中空針が一般的に使用されている。このため、針部102の生体内への穿刺、あるいは薬液の生体内への注入に伴って痛みが生じる。また、太い針を刺されることによって患者に与える恐怖感や、不安感が大きい。   However, in the conventional chemical solution injection needle 101 described above, a relatively thick hollow needle having an outer diameter larger than 0.25 mm is generally used as the needle portion 102. For this reason, pain arises with the puncture of the needle part 102 into the living body or the injection of the medical solution into the living body. Moreover, the fear and anxiety given to the patient by being stabbed with a thick needle are large.

一方、患者に与える痛みを低減するために従来よりも細い針部を使用しようとしても、このような細い針部を図18に示したように針部の長手方向中程にて基体部に強固に固着して組み立てるのはきわめて困難であるという問題が生じる。   On the other hand, even if an attempt is made to use a needle portion thinner than before in order to reduce pain given to the patient, such a thin needle portion is firmly attached to the base portion in the middle in the longitudinal direction of the needle portion as shown in FIG. There arises a problem that it is extremely difficult to fix and assemble.

また、上記のような細い針部は、強度的に弱くなる。したがって、薬液容器に薬液注入針を取り付けようとしても、針部を薬液容器の薬液注入口に設置されているゴム栓に貫通させることができずに、例えば折れてしまうおそれがある。   Further, the thin needle portion as described above is weak in strength. Therefore, even if it is going to attach a chemical injection needle to a chemical solution container, there is a possibility that the needle part cannot penetrate the rubber stopper installed in the chemical injection port of the chemical solution container, and breaks, for example.

さらに、上記のような細い針部は、必然的にその内径も小さくなり、しかもその長さが比較的長くなることから、薬液を生体内へ注入するときの流路抵抗(以下、「注入抵抗」という。)が非常に大きくなってしまう。このため、薬液注入時に薬液を押し出すための力がかなり必要になるという問題がある。   Furthermore, since the thin needle portion as described above inevitably has a small inner diameter and a relatively long length, the flow resistance (hereinafter referred to as “injection resistance”) ") Will become very large. For this reason, there exists a problem that the force for extruding a chemical | medical solution at the time of chemical | medical solution injection | emission needs considerably.

より詳述すると、例えば糖尿病患者が自分の皮内にインスリン含有液を経皮的に自己投与するための現在市販されている薬液注入装置において用いられている薬液注入針の針部は、最も細いもので、外径0.254mm(31ゲージ(G))である。なお、「ゲージ」とは、B.W.G.(Birmingham Wire Gage)の規格に基づいた数字である。   More specifically, for example, the needle portion of a drug injection needle used in a currently marketed drug injection device for transdermally self-administering an insulin-containing solution into the skin of a diabetic patient is the thinnest. It has an outer diameter of 0.254 mm (31 gauge (G)). “Gauge” means B.I. W. G. It is a number based on the (Birmingham Wire Gage) standard.

ところが、この外径0.254mm(31G)の針部を使用する場合、薬液を投与する際の注入抵抗がかなり高くなる。これは、理論上、針部における注入抵抗は、針部の直径の4乗に反比例して高くなるからである。このため、特に女性、子供、高齢者など、薬液注入装置のプランジャーを押す力の弱い患者が、外径0.254mm(31G)の針部を用いて自分の皮下に薬液を自己投与しようとしても、薬液がうまく皮下に入っていかない場合がある。このような場合、患者は、外径0.30mm(30G)などの、より太い、したがって、より強い痛みを感じさせる針部を使用しなければならない。   However, when this needle portion having an outer diameter of 0.254 mm (31 G) is used, the injection resistance when administering the drug solution is considerably increased. This is because, theoretically, the injection resistance in the needle portion increases in inverse proportion to the fourth power of the diameter of the needle portion. For this reason, especially patients, such as women, children, and elderly people, who are weak in pushing the plunger of the drug solution injection device, try to self-administer the drug solution under their own skin using a needle part with an outer diameter of 0.254 mm (31 G). However, the drug solution may not enter the skin well. In such cases, the patient must use a needle that is thicker and therefore more painful, such as an outer diameter of 0.30 mm (30 G).

また、外径0.254mm(31G)の針部を使用した場合、注射終了後にインスリン含有液が皮膚における穿刺口あるいは針部の先端から漏れ出してしまうことがある。このようなことが起こる原因の一つは、外径0.254mm(31G)のような細い針部では注入抵抗が高いため薬液の注入が終了するまでに時間を要し、所定の薬液量(所定のインスリン・ユニット)のすべてが皮下に完全に投与される前に患者が耐えきれずに針部を皮膚から抜いてしまうことにあると推察される。糖尿病治療においては、1回の注射で投与される薬液量(インスリン・ユニット)が患者に応じてあらかじめ定められており、注射のたびにこのあらかじめ決められた量の薬液が正確に投与されなければならない。したがって、注射終了後に薬液が漏れ出すということは、定められた量よりも少ない量しか患者に薬液が投与されておらず、よって十分な治療効果が得られないことを意味する。   In addition, when a needle part having an outer diameter of 0.254 mm (31 G) is used, the insulin-containing liquid may leak from the puncture opening in the skin or the tip of the needle part after completion of the injection. One of the causes of this occurrence is that a thin needle portion having an outer diameter of 0.254 mm (31 G) has a high injection resistance, so that it takes time to complete the injection of the chemical solution. It is surmised that the patient is unable to withstand and the needle is removed from the skin before all of the predetermined insulin unit) is completely administered subcutaneously. In the treatment of diabetes, the amount of solution (insulin unit) to be administered in a single injection is predetermined according to the patient, and this predetermined amount of solution must be administered accurately for each injection. Don't be. Therefore, the leakage of the drug solution after the end of the injection means that the drug solution is administered to the patient in an amount smaller than a predetermined amount, and thus a sufficient therapeutic effect cannot be obtained.

一方、別の分野では、例えば患者の歯髄内に麻酔薬(リドカイン)を注入するための歯科用薬液注入装置が用いられている。現在市販されている歯科用薬液注入装置の針部(デンタル針)は、最も細いもので、外径0.26mmである。この外径0.26mmの針部を用いて麻酔薬を歯茎等に注入する際にも、かなり高い注入抵抗が存在する。ここで、歯科用薬液注入装置の本体およびプランジャーは金属製であり、かつ健常人である医者が歯科用薬液注入装置を用いて麻酔薬を注入する。したがって、医者が思いきり強くプランジャーを押すことにより、上記のような細い針部でも麻酔薬の注入が可能となる。   On the other hand, in another field, for example, a dental liquid injector for injecting an anesthetic (lidocaine) into the dental pulp of a patient is used. The needle part (dental needle) of a dental chemical injection device currently on the market is the thinnest and has an outer diameter of 0.26 mm. Even when an anesthetic is injected into a gum or the like using the needle portion having an outer diameter of 0.26 mm, there is a considerably high injection resistance. Here, the main body and the plunger of the dental liquid injector are made of metal, and a healthy doctor injects an anesthetic using the dental liquid injector. Therefore, when the doctor pushes the plunger firmly, the anesthetic can be injected even with the thin needle as described above.

しかしながら、この歯科用薬液注入装置においても、より軽い力で麻酔薬を注入できるように注入抵抗を低減すること、さらに、より細い針部を用いることにより患者に与える苦痛等を和らげることが望ましい。また、注射器を金属製とすると重くなる。したがって、針部における注入抵抗を低減することができれば、プラスチック等のより軽量な材料を利用して注入装置を構成することが可能となり、より取り扱い易い歯科用薬液注入装置を提供できると考えられる。   However, in this dental chemical solution injection device, it is desirable to reduce injection resistance so that anesthetic can be injected with a lighter force, and to relieve pain and the like given to the patient by using a thinner needle part. Moreover, if the syringe is made of metal, it becomes heavy. Therefore, if the injection resistance in the needle portion can be reduced, it is possible to configure an injection device using a lighter material such as plastic, and it is considered that a dental chemical injection device that is easier to handle can be provided.

以上述べたように、患者に与える痛みを抑えるために単に針部の外径を小さくすることは、上記のような種々の問題が生じてしまうため、実際上、実現することができなかった。   As described above, simply reducing the outer diameter of the needle portion in order to suppress the pain given to the patient has caused various problems as described above, and thus could not be actually realized.

本発明は、上述の課題を解決するためになされたものであり、その目的は、患者に与える痛みを低減することができ、かつ製造が容易で、針部を例えばゴム栓に貫通できる強度を有し、しかも注入抵抗を低減することができる液体注入針および液体注入装置を提供することである。   The present invention has been made in order to solve the above-mentioned problems, and its purpose is to reduce the pain given to a patient, and to make it easy to manufacture and to have a strength capable of penetrating a needle part, for example, a rubber stopper. It is another object of the present invention to provide a liquid injection needle and a liquid injection device that can reduce injection resistance.

本発明の目的は、下記する手段により達成される。   The object of the present invention is achieved by the following means.

(1) 内部に液体が収容される液体容器の先端部に形成された液体注入口に取り付けられる液体注入針であって、生体内に穿刺可能な穿刺部を備えた穿刺針部と、前記液体容器内に連通可能な液体導入針部と、前記穿刺針部および前記液体導入針部間を液体が流通可能な状態で当該両針部を支持する基体部とを有し、前記液体導入針部は、前記穿刺部の少なくとも先端近傍よりも外径が大きく、前記液体導入針部の端部に、前記液体容器の液体注入口を封止する弾性部材を貫くための刃先が形成されており、前記穿刺針部と前記液体導入針部とは、同じ一つの針体により形成されており、前記穿刺針部は、前記穿刺部と前記液体導入針部との間に形成され外径が連続的に変化して両者を滑らかに繋ぐ中間部を有し、前記穿刺部の外径は0.1mm以上0.254mm以下、前記穿刺部の内径は0.05mm以上0.15mm以下であることを特徴とする液体注入針。   (1) A liquid injection needle attached to a liquid injection port formed at a tip of a liquid container in which a liquid is accommodated, the puncture needle unit having a puncture unit capable of puncturing in a living body, and the liquid A liquid introduction needle portion that can communicate with a container, and a base portion that supports the needle portion in a state in which liquid can flow between the puncture needle portion and the liquid introduction needle portion, and the liquid introduction needle portion The outer diameter is larger than at least the vicinity of the tip of the puncture part, and the edge of the liquid introduction needle part is formed with a cutting edge for penetrating an elastic member that seals the liquid inlet of the liquid container, The puncture needle portion and the liquid introduction needle portion are formed of the same single needle body, and the puncture needle portion is formed between the puncture portion and the liquid introduction needle portion and has a continuous outer diameter. And the outer diameter of the puncture portion is 0. 0. mm above 0.254mm or less, the liquid injection needle, wherein the inner diameter of the puncture section is 0.05mm or 0.15mm or less.

(2) 前記穿刺針部のうち基体部の底部壁から外方へ突出した部分の長さは、0.5mm以上10mm以下であることを特徴とする上記(1)に記載の液体注入針。   (2) The liquid injection needle according to (1), wherein a length of a portion of the puncture needle portion protruding outward from a bottom wall of the base portion is 0.5 mm or more and 10 mm or less.

(3) 前記穿刺部の外径は、0.1mm以上、0.25mm以下であることを特徴とする上記(1)または(2)に記載の液体注入針。   (3) The liquid injection needle according to (1) or (2) above, wherein an outer diameter of the puncture portion is 0.1 mm or more and 0.25 mm or less.

(4) 前記穿刺部の外径は、0.18mm以上、0.22mm以下であることを特徴とする上記(1)または(2)に記載の液体注入針。   (4) The liquid injection needle according to (1) or (2) above, wherein an outer diameter of the puncture portion is 0.18 mm or more and 0.22 mm or less.

(5) 前記液体は、生体に作用する薬剤を含むことを特徴とする上記(1)〜(4)のいずれか1つに記載の液体注入針。   (5) The liquid injection needle according to any one of (1) to (4), wherein the liquid includes a drug acting on a living body.

(6) 先端部に液体注入口が形成され内部に液体が収容される液体容器と、前記液体容器の液体注入口に取り付けられる上記(1)〜(5)のいずれか1項に記載の液体注入針とを有することを特徴とする液体注入装置。   (6) The liquid container according to any one of (1) to (5) above, which is attached to the liquid inlet of the liquid container, and the liquid container in which the liquid inlet is formed at the distal end portion and contains the liquid A liquid injection apparatus comprising an injection needle.

以上説明したように、本発明によれば、針部のうち生体内に穿刺可能な穿刺部を従来よりも細くすることができる。このため、痛みに関係する神経網に対する針部の接触面積を低下させることができ、神経網への刺激が低下して、患者に与える痛みを低減することができる。   As described above, according to the present invention, the puncture portion that can be punctured in the living body among the needle portions can be made thinner than the conventional one. For this reason, the contact area of the needle part with respect to the nerve network related to pain can be reduced, the stimulation to the nerve network can be reduced, and the pain given to the patient can be reduced.

また、本発明の液体注入針は、細い一定の径の針部をその長手方向中程にて基体部に固着して組み立てるものではない。したがって、針部の穿刺部が細くても、薬液注入針を組立製造することが容易となる。   Further, the liquid injection needle of the present invention is not assembled by fixing a thin needle portion having a constant diameter to the base portion in the middle in the longitudinal direction. Therefore, even if the puncture portion of the needle portion is thin, it is easy to assemble and manufacture the chemical solution injection needle.

また、比較的外径が大きい液体導入針部の端部に、液体容器の液体注入口を封止する弾性部材を貫くための刃先を形成できるので、弾性部材を貫くために必要な強度を十分確保することができる。したがって、例えば折れてしまって針部を弾性部材に貫通させることができないといった事態を防止することができる。   In addition, since a blade edge for penetrating the elastic member for sealing the liquid inlet of the liquid container can be formed at the end of the liquid introduction needle portion having a relatively large outer diameter, the strength necessary for penetrating the elastic member is sufficient. Can be secured. Therefore, for example, it is possible to prevent a situation in which the needle part cannot be penetrated through the elastic member because it is broken.

さらに、薬液導入針部を穿刺部の少なくとも先端近傍よりも太くできるので、例えば外径に応じた内径とすることによって針部における注入抵抗を低減することが可能となる。この場合、薬液を押し出すための力が少なくて済み、薬液を生体内へ良好に注入することができる。   Furthermore, since the medicinal solution introduction needle portion can be made thicker than at least the vicinity of the tip of the puncture portion, for example, by setting the inner diameter in accordance with the outer diameter, the injection resistance in the needle portion can be reduced. In this case, the force for extruding the drug solution is small, and the drug solution can be injected well into the living body.

以下、本発明の実施の形態を、図面を参照して説明する。   Hereinafter, embodiments of the present invention will be described with reference to the drawings.

図1は、本発明の第1の実施形態に係る薬液注入針が取り付けられた薬液注入装置の断面図、図2は、図1に示される注入器本体の断面図、図3は、図1に示される薬液注入針の側面図、図4は、図1に示される薬液注入針の断面図である。   1 is a cross-sectional view of a chemical liquid injection device to which a chemical liquid injection needle according to a first embodiment of the present invention is attached, FIG. 2 is a cross-sectional view of the injector main body shown in FIG. 1, and FIG. 4 is a side view of the chemical liquid injection needle shown in FIG. 4, and FIG. 4 is a cross-sectional view of the chemical liquid injection needle shown in FIG.

図1に示す薬液注入装置は、薬液注入針1と注入器本体5とから構成されており、プランジャー52が押されることにより、薬液60を薬液注入針1の先端から生体内に注入するものである。   The chemical injection device shown in FIG. 1 is composed of a chemical injection needle 1 and an injector body 5, and injects a chemical 60 into the living body from the tip of the chemical injection needle 1 when the plunger 52 is pushed. It is.

図2に示すように、注入器本体5は、内部に薬液60を収容する略円筒状の薬液容器51と、薬液容器51の内部で長手方向に往復動可能なプランジャー52とを備えている。   As shown in FIG. 2, the injector main body 5 includes a substantially cylindrical chemical solution container 51 that contains a chemical solution 60 therein, and a plunger 52 that can reciprocate in the longitudinal direction inside the chemical solution container 51. .

薬液容器51の先端側(図中左側)のボス部53には、薬液注入口54が形成されており、この薬液注入口54は、例えばゴム栓などの弾性部材55により封止されている。弾性部材55は、ボス部53の内面に形成された溝56に嵌着されて保持される。また、ボス部53の外面には、薬液注入針1を取り付けるときに使用される雄ねじ57が形成されている。   A chemical solution injection port 54 is formed in the boss portion 53 on the distal end side (left side in the figure) of the chemical solution container 51, and this chemical solution injection port 54 is sealed by an elastic member 55 such as a rubber plug. The elastic member 55 is fitted and held in a groove 56 formed on the inner surface of the boss portion 53. Further, a male screw 57 that is used when the chemical injection needle 1 is attached is formed on the outer surface of the boss portion 53.

一方、薬液容器51の基端側(図中右側)には、開口58が形成されている。プランジャー52は、開口58から内部に挿入される。このプランジャー52の先端には、ガスケット59が取り付けられている。ガスケット59は、薬液容器51の内面に密着して薬液を後方に漏らさないようにシールし、先端側に移動することにより薬液60を前方に押し出す役目を果たす。   On the other hand, an opening 58 is formed on the proximal end side (right side in the drawing) of the chemical solution container 51. The plunger 52 is inserted into the inside through the opening 58. A gasket 59 is attached to the tip of the plunger 52. The gasket 59 is in close contact with the inner surface of the chemical liquid container 51 to seal the chemical liquid so that it does not leak backward, and moves to the tip side to push the chemical liquid 60 forward.

弾性部材55とガスケット59との間には、薬液60が充填されている。この薬液注入装置で使用される薬液60は、薬剤を含有する溶液、ゲル、または懸濁液である。使用可能な薬剤は、経皮的な投与に適さない薬剤以外であるならば、実質的に制限されない。また、薬剤は、局所的に作用するものであっても、全身的に作用するものであってもよい。   A chemical solution 60 is filled between the elastic member 55 and the gasket 59. The chemical solution 60 used in this chemical solution injection device is a solution, gel, or suspension containing a drug. The drugs that can be used are not substantially limited as long as they are other than drugs that are not suitable for transdermal administration. The drug may act locally or act systemically.

弾性部材55とガスケット59とは、例えばブチルゴム、シリコンゴム、あるいはエラストマー等の材料を使用して、成形加工により作られる。薬液容器51とプランジャー52とは、例えばポリプロピレン、ポリエチレンなどのプラスチック、あるいはガラス等の材料を使用して、成形加工により作られる。なお、薬液容器51は、その全部または一部が透明な材料より形成されており、内部に収容された薬液を目視で確認することができる。   The elastic member 55 and the gasket 59 are made by molding using a material such as butyl rubber, silicon rubber, or elastomer, for example. The chemical solution container 51 and the plunger 52 are made by molding using a material such as plastic, such as polypropylene or polyethylene, or glass. The chemical solution container 51 is formed entirely or partially from a transparent material, and the chemical solution accommodated therein can be visually confirmed.

図3および図4に示すように、薬液注入針1は、生体内に穿刺可能な穿刺部21を備えた穿刺針部2と、薬液容器51内に連通可能な液体導入針部3と、これら穿刺針部2および液体導入針部3の間を薬液が流通可能な状態で当該両針部2、3を支持する基体部であるハウジング4とを備えている。第1の実施形態では、図示のように、穿刺針部2と液体導入針部3とは、同じ一つの針体により形成されている。   As shown in FIGS. 3 and 4, the drug solution injection needle 1 includes a puncture needle unit 2 having a puncture unit 21 that can be punctured in a living body, a liquid introduction needle unit 3 that can communicate with a drug solution container 51, and these A housing 4 is provided as a base portion that supports the needles 2 and 3 in a state in which a drug solution can flow between the puncture needle 2 and the liquid introduction needle 3. In the first embodiment, as shown in the figure, the puncture needle portion 2 and the liquid introduction needle portion 3 are formed by the same single needle body.

ハウジング4は、円筒部41と、円筒部41の一端に形成された底部壁42とを備えている。円筒部41の内面には、薬液容器51のボス部53に形成された雄ねじ57に螺合される雌ねじ43が形成されている。   The housing 4 includes a cylindrical portion 41 and a bottom wall 42 formed at one end of the cylindrical portion 41. On the inner surface of the cylindrical portion 41, a female screw 43 that is screwed into a male screw 57 formed on the boss portion 53 of the chemical liquid container 51 is formed.

穿刺針部2および液体導入針部3は、中空針から構成されている。穿刺針部2は、薬液注入針1の先端側に形成され、液体導入針部3は、穿刺針部2の基端側に形成される。そして、液体導入針部3は、穿刺針部2の穿刺部21よりも外径が大きく設定されている。   The puncture needle portion 2 and the liquid introduction needle portion 3 are constituted by hollow needles. The puncture needle portion 2 is formed on the distal end side of the drug solution injection needle 1, and the liquid introduction needle portion 3 is formed on the proximal end side of the puncture needle portion 2. The liquid introduction needle portion 3 is set to have an outer diameter larger than that of the puncture portion 21 of the puncture needle portion 2.

本実施形態では特に、穿刺針部2の穿刺部21の外径は、好ましくは0.254mm(31G)以下、より好ましくは0.1mm以上、0.25mm以下、さらに好ましくは0.18mm以上、0.22mm以下に設定される。このように、穿刺部21の外径の上限は、患者に与える穿刺痛を低減する観点から、従来の31Gの針と同程度もしくは従来よりも小さく設定され、その下限は、所定の強度を確保し、注入抵抗の増大を抑える観点から設定される。これに伴って、穿刺部21の内径は、0.05mm以上、0.15mm以下が望ましい。なお、従来の外径0.254mm(31G)と同じに穿刺部21の外径を形成しても、液体導入部3の外径が大きいため、注入抵抗の低減の点で従来の31Gの針よりも優れた針を提供できる。   Particularly in the present embodiment, the outer diameter of the puncture portion 21 of the puncture needle portion 2 is preferably 0.254 mm (31 G) or less, more preferably 0.1 mm or more, 0.25 mm or less, and further preferably 0.18 mm or more. It is set to 0.22 mm or less. Thus, from the viewpoint of reducing the puncture pain given to the patient, the upper limit of the outer diameter of the puncture unit 21 is set to be the same as or smaller than the conventional 31G needle, and the lower limit is set to a predetermined strength. It is set from the viewpoint of securing and suppressing an increase in injection resistance. Accordingly, the inner diameter of the puncture portion 21 is desirably 0.05 mm or more and 0.15 mm or less. Even if the outer diameter of the puncture portion 21 is formed in the same manner as the conventional outer diameter of 0.254 mm (31 G), the outer diameter of the liquid introduction portion 3 is large, so that the conventional 31G needle is reduced in terms of reducing injection resistance. Better needles can be provided.

また、穿刺針部2の穿刺部21の長さは、好ましくは0.2mm以上、15mm以下、より好ましくは0.5mm以上、10mm以下である。ここで、穿刺部21の長さは、穿刺針部2のうちハウジング4の底部壁42から外方へ突出した部分の長さに相当する。穿刺部21の長さは、従来、皮下・筋肉内投与では10〜40mmが一般的である。これに対し、本実施形態では、好ましくは、穿刺部21の長さの上限は、所定の強度を確保し、注入抵抗の増大を抑える観点から従来よりも短く設定され、その下限は、生体内への穿刺を所望どおり良好に行う観点から設定される。   Moreover, the length of the puncture part 21 of the puncture needle part 2 is preferably 0.2 mm or more and 15 mm or less, more preferably 0.5 mm or more and 10 mm or less. Here, the length of the puncture portion 21 corresponds to the length of the portion of the puncture needle portion 2 that protrudes outward from the bottom wall 42 of the housing 4. Conventionally, the length of the puncture part 21 is generally 10 to 40 mm for subcutaneous and intramuscular administration. On the other hand, in the present embodiment, preferably, the upper limit of the length of the puncture portion 21 is set shorter than the conventional in view of securing a predetermined strength and suppressing an increase in injection resistance, and the lower limit is set in vivo. It is set from the viewpoint of successfully performing puncture to the desired as desired.

一方、薬液導入針部3の外径は、好ましくは0.3mm以上、0.6mm以下、より好ましくは0.35mm以上、0.5mm以下である。このように、薬液導入針部3の外径の下限は、後述する刃先31が形成される部分の強度を向上させるとともに、注入抵抗を積極的に低減する観点から、前述したように穿刺針部2よりも大きく設定され、その上限は、刃先31が薬液注入口54を封止する弾性部材55を容易に貫通可能とするとともに、製造容易性の観点から設定される。これに伴って、薬液導入針部3の内径は、0.25mm以上、0.5mm以下が望ましい。   On the other hand, the outer diameter of the chemical solution introduction needle portion 3 is preferably 0.3 mm or more and 0.6 mm or less, more preferably 0.35 mm or more and 0.5 mm or less. Thus, the lower limit of the outer diameter of the drug solution introduction needle portion 3 improves the strength of the portion where the blade tip 31 described later is formed and also positively reduces the injection resistance as described above, as described above. The upper limit is set from the viewpoint of manufacturability while allowing the cutting edge 31 to easily penetrate the elastic member 55 that seals the chemical liquid inlet 54. Accordingly, the inner diameter of the chemical solution introduction needle portion 3 is preferably 0.25 mm or more and 0.5 mm or less.

薬液導入針部3の基端側の端部には、薬液容器51の先端部に形成された薬液注入口54を封止する弾性部材55を貫くための刃先31が形成されている。刃先31は、例えば、薬液導入針部3の端部を斜めにカットすることにより形成される。この刃先31は、薬液注入針1の薬液容器51への取り付け時に、弾性部材55に突き刺されて貫通する。   A cutting edge 31 for penetrating an elastic member 55 that seals the chemical solution inlet 54 formed at the distal end portion of the chemical solution container 51 is formed at the proximal end side of the chemical solution introduction needle portion 3. The blade edge 31 is formed by, for example, cutting the end portion of the chemical solution introduction needle portion 3 obliquely. The cutting edge 31 is pierced and penetrated by the elastic member 55 when the chemical liquid injection needle 1 is attached to the chemical liquid container 51.

また、穿刺針部2は、穿刺部21と液体導入針部3との間に形成され外径が連続的に変化して両者を滑らかに繋ぐ中間部22を有している。薬液注入針1が皮内・皮下用の短針の場合、中間部22は、ハウジング4の底部壁42の中央部に挿通された状態で固着される。   Further, the puncture needle portion 2 has an intermediate portion 22 formed between the puncture portion 21 and the liquid introduction needle portion 3 so that the outer diameter changes continuously and smoothly connects the two. When the drug solution injection needle 1 is an intradermal / subcutaneous short needle, the intermediate portion 22 is fixed in a state of being inserted into the center portion of the bottom wall 42 of the housing 4.

なお、薬液注入針1が皮下・筋肉内用の長針の場合、生体内に穿刺可能な部分のすべてが液体導入針部3よりも細くなる必要はない。例えば図5に示すように、外径が連続的に変化する中間部22もまた生体内に穿刺可能とされ、結果的に中間部22が穿刺部21のうちに含まれるように構成されていてもよい。この場合、中間部22よりも基端側の外径が一定で太い部分がハウジング4の底部壁42の中央部に挿通された状態で固着される。   When the drug solution injection needle 1 is a long needle for subcutaneous and intramuscular use, it is not necessary that all the parts that can be punctured in the living body are thinner than the liquid introduction needle part 3. For example, as shown in FIG. 5, the intermediate part 22 whose outer diameter continuously changes can also be punctured into the living body, and as a result, the intermediate part 22 is configured to be included in the puncture part 21. Also good. In this case, the outer diameter on the base end side with respect to the intermediate portion 22 is fixed and the thick portion is fixed in a state of being inserted into the central portion of the bottom wall 42 of the housing 4.

また、本発明では、例えば図6に示すように、穿刺部21からハウジング4の底部壁42に固着された部分にかけての形状は、必ずしも外径が一様な図4に示したような形状に限定されるものではなく、連続的に外径を変化させた形状としてもよい。   Further, in the present invention, for example, as shown in FIG. 6, the shape from the puncture portion 21 to the portion fixed to the bottom wall 42 of the housing 4 is not necessarily the same shape as shown in FIG. The shape is not limited, and the outer diameter may be continuously changed.

中間部22は、先細の形状を呈しており、軸心に沿う平面で切断された断面の外形線は、直線状あるいは凹状を呈している。特に図4、図5および図6に示す中間部22は、先端側に向かってその内径が漸減するような形状(テーパ形状)をなしている。これにより、薬液は、液体導入部3から中間部22を経て穿刺部21へと流れる際にその流速が加速され、勢いよく流れる。   The intermediate portion 22 has a tapered shape, and the outline of the cross section cut by a plane along the axis is linear or concave. In particular, the intermediate portion 22 shown in FIGS. 4, 5, and 6 has a shape (tapered shape) in which the inner diameter gradually decreases toward the tip side. Thereby, when the chemical liquid flows from the liquid introduction part 3 through the intermediate part 22 to the puncture part 21, the flow rate is accelerated and flows vigorously.

ハウジング4は、例えばポリプロピレン、ポリエチレンなどのプラスチック、あるいはガラス等の材料を使用して、成形加工により作られる。穿刺針部2および液体導入針部3は、一般的にはステンレス鋼を使用して、例えば塑性加工により作られる。但し、例えばチタンなどの他の金属、あるいはプラスチック等の材料から針部2、3を作ることも可能である。   The housing 4 is made by molding using a material such as plastic, such as polypropylene or polyethylene, or glass. The puncture needle portion 2 and the liquid introduction needle portion 3 are generally made of stainless steel, for example, by plastic working. However, it is also possible to make the needle portions 2 and 3 from other metals such as titanium or a material such as plastic.

穿刺針部2および液体導入針部3のハウジング4への固着は、例えば図4に示したような形で、インサート成形、あるいは接着により行われる。なお、針部2、3を単に一律に細くしたのでは針部2、3のハウジング4に対する接合力が小さくなってしまうため、針部2、3がハウジング4から先端側へ抜け落ちるおそれがある。これに対し、本実施形態では、針部2、3が、外径が滑らかに拡大している中間部あるいは中間部よりも基端側の太い外径の部分においてハウジング4と接合されているため、針部2、3が先端側へ脱落するおそれは無くなる。また、針部2、3とハウジング4との接合面積が増えるため針部2、3をハウジング4に強固に固着することが可能となる。したがって、穿刺針部2の穿刺部21が細くても、薬液注入針1を組立製造することが容易となる。   The puncture needle portion 2 and the liquid introduction needle portion 3 are fixed to the housing 4 by, for example, insert molding or adhesion in the form shown in FIG. If the needle portions 2 and 3 are simply made thin, the bonding force of the needle portions 2 and 3 to the housing 4 is reduced, and the needle portions 2 and 3 may fall out of the housing 4 toward the distal end side. On the other hand, in the present embodiment, the needle portions 2 and 3 are joined to the housing 4 at the middle portion where the outer diameter is smoothly expanded or at the portion having a larger outer diameter on the base end side than the middle portion. There is no possibility that the needle portions 2 and 3 fall off to the tip side. Further, since the joining area between the needle portions 2 and 3 and the housing 4 increases, the needle portions 2 and 3 can be firmly fixed to the housing 4. Therefore, even if the puncture portion 21 of the puncture needle portion 2 is thin, it is easy to assemble and manufacture the drug solution injection needle 1.

次に、薬液注入針を薬液容器に取り付けて、薬液注入装置を使用する方法について説明する。   Next, a method of using the chemical solution injection device with the chemical solution injection needle attached to the chemical solution container will be described.

まず、薬液注入針1のハウジング4を薬液容器51のボス部53に外挿し、液体導入針部3の端部に形成された刃先31を弾性部材55に刺通させる。これにより、針部2、3内と薬液容器51内とが連通される。つづいて、薬液容器51のボス部53に形成された雄ねじ57に、薬液注入針1のハウジング4の内面に形成された雌ねじ43を螺合させることにより、薬液注入針1を薬液容器51にねじ込む。   First, the housing 4 of the chemical solution injection needle 1 is extrapolated to the boss portion 53 of the chemical solution container 51, and the cutting edge 31 formed at the end portion of the liquid introduction needle portion 3 is pierced through the elastic member 55. Thereby, the inside of the needle parts 2 and 3 and the inside of the chemical | medical solution container 51 are connected. Subsequently, the medicinal solution injection needle 1 is screwed into the medicinal solution container 51 by screwing the female screw 43 formed on the inner surface of the housing 4 of the medicinal solution injection needle 1 with the male screw 57 formed on the boss portion 53 of the medicinal solution container 51. .

ここで、薬液導入針部3の外径は、穿刺針部2の穿刺部21よりも大きく設定されているので、弾性部材55を貫くために必要な強度を十分確保することができる。したがって、例えば折れてしまって薬液導入針部3を弾性部材55に貫通させることができないといった事態を防止することができる。   Here, since the outer diameter of the drug solution introduction needle portion 3 is set to be larger than that of the puncture portion 21 of the puncture needle portion 2, it is possible to sufficiently ensure the strength necessary for penetrating the elastic member 55. Therefore, for example, it is possible to prevent a situation in which the chemical solution introduction needle portion 3 cannot be penetrated through the elastic member 55 due to breakage.

このようにして薬液注入針1が薬液容器51に取り付けられ、薬液注入装置の使用準備が完了する。次いで、薬液注入装置の薬液注入針1を、薬液注入対象となる患者の生体内に穿刺する。しかし、穿刺針部2の穿刺部21が従来よりも細いため、痛みに関係する神経網に対する針部の接触面積を低下させることができ、神経網への刺激が低下して、痛みの発生が低減される。   In this way, the chemical liquid injection needle 1 is attached to the chemical liquid container 51, and preparation for use of the chemical liquid injection apparatus is completed. Next, the drug solution injection needle 1 of the drug solution injection device is punctured into the living body of the patient to be injected with the drug solution. However, since the puncture portion 21 of the puncture needle portion 2 is thinner than before, the contact area of the needle portion with the nerve network related to pain can be reduced, the stimulation to the nerve network is reduced, and pain is generated. Reduced.

そして、注入器本体5のプランジャー52を押すことにより、薬液容器51内の薬液60は、薬液注入針1の針部2、3を通って、患者の例えば皮内、皮下、筋肉、あるいは各種臓器等の生体内に注入される。   Then, by pushing the plunger 52 of the injector body 5, the drug solution 60 in the drug solution container 51 passes through the needle parts 2 and 3 of the drug solution injection needle 1, for example, intradermal, subcutaneous, muscle, or various It is injected into a living body such as an organ.

ここで、薬液導入針部3の外径が比較的大きく設定されていることから、薬液導入針部3の内径も大きく設定することができ、針部における注入抵抗を低減することが可能となる。したがって、プランジャー52を押して薬液を押し出すための力が少なくて済み、薬液を生体内へ良好に注入することができる。   Here, since the outer diameter of the chemical solution introduction needle portion 3 is set to be relatively large, the inner diameter of the chemical solution introduction needle portion 3 can also be set to be large, and the injection resistance in the needle portion can be reduced. . Therefore, the force for pushing the plunger 52 to push out the chemical solution is small, and the chemical solution can be injected well into the living body.

このように本実施形態では、針部のうち患者に穿刺される部分を細く、針部のそれ以外の部分を比較的太くすることにより、痛みの無い、もしくは痛みのきわめて少ない細い薬液注入針でありながら、注入抵抗も少ない薬液注入針を提供することができる。特に、穿刺部21の外径を0.254mm(31G)以下、好ましくは0.1mm以上、0.25mm以下、より好ましくは0.18mm以上、0.22mm以下に構成することにより、現在市販されているいちばん細い針と同等もしくは現在市販されているいかなる薬液注入針よりも細い穿刺部を備えながら、注入抵抗も小さくすることができる。したがって、痛みが無いかもしくは痛みがきわめて少なく、かつ例えば、女性、子供、高齢者などの体力的あるいは精神的に虚弱な患者が薬液を自己投与する場合であっても、困難なく、しかも迅速に薬液を投与することができる薬液注入針および薬液注入装置を提供することができる。   As described above, in the present embodiment, by narrowing the portion of the needle portion that is punctured by the patient and relatively thickening the other portion of the needle portion, it is possible to use a thin drug injection needle that has no pain or very little pain. Nevertheless, it is possible to provide a chemical injection needle with low injection resistance. In particular, the outer diameter of the puncture portion 21 is 0.254 mm (31 G) or less, preferably 0.1 mm or more and 0.25 mm or less, more preferably 0.18 mm or more and 0.22 mm or less, so that it is currently marketed. The injection resistance can be reduced while providing a puncture portion equivalent to the thinnest needle or thinner than any drug injection needle currently on the market. Therefore, even if there is no pain or very little pain, and a physically or mentally weak patient such as a woman, child, elderly person, etc. self-administers the drug solution, it is difficult and quick. A chemical injection needle and a chemical injection device that can administer a chemical can be provided.

なお、図3〜図6に示す薬液注入針1は、1本の針体から構成される針部2、3のみを有しているが、本発明の薬液注入針はこれに限られず、1つのハウジング4に複数本の針体が取り付けられていてもよい。このようにすれば、薬液の注入量を増やすことができる。また、薬液が分散されて生体内に注入されるので、薬物の迅速な効果が期待できる。   3 to 6 have only the needle portions 2 and 3 formed of a single needle body, the chemical liquid injection needle of the present invention is not limited to this. A plurality of needle bodies may be attached to one housing 4. If it does in this way, the injection amount of a chemical | medical solution can be increased. In addition, since the drug solution is dispersed and injected into the living body, a rapid effect of the drug can be expected.

図7は、本発明の第2の実施形態に係る薬液注入針の側面図、図8は、図7に示される薬液注入針の断面図である。なお、以下においては、上記の第1の実施形態と相違する点を主に説明し、共通する点については適宜説明を省略する。   FIG. 7 is a side view of a chemical liquid injection needle according to the second embodiment of the present invention, and FIG. 8 is a cross-sectional view of the chemical liquid injection needle shown in FIG. In the following, differences from the first embodiment will be mainly described, and description of common points will be omitted as appropriate.

本発明の第2の実施形態に係る薬液注入装置は、第1の実施形態に対し、薬液注入針の構成のみが相違しており、注入器本体5の構成は同じである。   The chemical injection device according to the second embodiment of the present invention is different from the first embodiment only in the configuration of the chemical injection needle, and the configuration of the injector body 5 is the same.

図7および図8に示すように、薬液注入針1aは、生体内に穿刺可能な穿刺部21aを備えた穿刺針部2aと、液体容器51内に連通可能な液体導入針部3aと、これら穿刺針部2aおよび液体導入針部3aの間を薬液が流通可能な状態で当該両針部2a、3aを支持するハウジング4aとを備えている。図示のように、第2の実施形態に係る薬液注入針1aは、穿刺針部2aと薬液導入針部3aとが別々の独立した針体により形成されている点で、穿刺針部2と液体導入針部3とが同じ一つの針体により形成されている第1の実施形態と相違している。   As shown in FIGS. 7 and 8, the chemical injection needle 1a includes a puncture needle portion 2a having a puncture portion 21a that can be punctured in a living body, a liquid introduction needle portion 3a that can communicate with the liquid container 51, and these And a housing 4a that supports the needles 2a and 3a in a state in which a drug solution can flow between the puncture needle 2a and the liquid introduction needle 3a. As shown in the figure, the medicinal solution injection needle 1a according to the second embodiment has a puncture needle portion 2 and a liquid in that the puncture needle portion 2a and the medicinal solution introduction needle portion 3a are formed by separate and independent needle bodies. This is different from the first embodiment in which the introduction needle portion 3 is formed by the same single needle body.

ハウジング4aは、円筒部41aと、円筒部41aの一端に形成された底部壁42aとを備えている。円筒部41aの内面には、薬液容器51のボス部53に形成された雄ねじ57に螺合される雌ねじ43aが形成されている。   The housing 4a includes a cylindrical portion 41a and a bottom wall 42a formed at one end of the cylindrical portion 41a. On the inner surface of the cylindrical portion 41a, a female screw 43a that is screwed into a male screw 57 formed on the boss portion 53 of the chemical liquid container 51 is formed.

穿刺針部2aは、上述した実施形態の穿刺針部2と同様な材料により作られる中空針から構成されている。この穿刺針部2aは、根元部22aがハウジング4aの底部壁42aの先端側に形成された取付用孔44aに挿入された状態で、ハウジング4aに固着される。   The puncture needle part 2a is comprised from the hollow needle made from the material similar to the puncture needle part 2 of embodiment mentioned above. The puncture needle portion 2a is fixed to the housing 4a in a state where the root portion 22a is inserted into a mounting hole 44a formed on the distal end side of the bottom wall 42a of the housing 4a.

液体導入針部3aもまた、上述した実施形態の液体導入針部3と同様な材料により作られる中空針から構成されている。この液体導入針部3aは、根元部32aがハウジング4aの底部壁42aの基端側に形成された取付用孔45aに挿入された状態で、ハウジング4aに固着される。そして、液体導入針部3aは、穿刺針部2aの穿刺部21aよりも外径が大きく設定される。   The liquid introduction needle portion 3a is also composed of a hollow needle made of the same material as that of the liquid introduction needle portion 3 of the above-described embodiment. The liquid introduction needle portion 3a is fixed to the housing 4a in a state where the root portion 32a is inserted into a mounting hole 45a formed on the base end side of the bottom wall 42a of the housing 4a. The liquid introduction needle portion 3a is set to have a larger outer diameter than the puncture portion 21a of the puncture needle portion 2a.

ハウジング4aには、穿刺針部2aおよび液体導入針部3aの間を繋ぐための孔46aが形成されている。   The housing 4a is formed with a hole 46a for connecting between the puncture needle portion 2a and the liquid introduction needle portion 3a.

第2の実施形態では、薬液導入針部3aの外径は、好ましくは0.3mm以上、2mm以下、より好ましくは0.35mm以上、1.5mm以下である。これに伴って、薬液導入針部3aの内径は、0.25mm以上、1.2mm以下が望ましい。   In 2nd Embodiment, the outer diameter of the chemical | medical solution introduction needle | hook part 3a becomes like this. Preferably they are 0.3 mm or more and 2 mm or less, More preferably, they are 0.35 mm or more and 1.5 mm or less. Accordingly, the inner diameter of the chemical solution introduction needle 3a is preferably 0.25 mm or more and 1.2 mm or less.

穿刺針部2aおよび液体導入針部3aのハウジング4aへの固着は、例えば図8に示したような形で、インサート成形、あるいは接着により行われる。ここで、図8に示すように、穿刺針部2aと薬液導入針部3aとは、別々の独立した針体により形成されているので、薬液注入針1aを特殊な製法を必要とせずに従来と同様な方法で簡便に作ることができる。しかも、針部2a、3aは、それぞれ取付用孔44a、45aに係合された状態となるので、ハウジング4aに強固に固着される。   The puncture needle portion 2a and the liquid introduction needle portion 3a are fixed to the housing 4a, for example, in the form shown in FIG. 8 by insert molding or adhesion. Here, as shown in FIG. 8, the puncture needle portion 2a and the drug solution introduction needle portion 3a are formed by separate and independent needle bodies, so that the drug solution injection needle 1a is not required to have a special manufacturing method. It can be easily made by the same method as above. Moreover, since the needle portions 2a and 3a are engaged with the mounting holes 44a and 45a, respectively, they are firmly fixed to the housing 4a.

なお、薬液注入針1aが皮下・筋肉内用の長針の場合、生体内に穿刺可能な部分のすべてが液体導入針部3aよりも細くなる必要はない。例えば図9に示すように、外径が連続的に変化する部分もまた生体内に穿刺可能とされ、結果的に、基端側に位置する外径が一定で太い部分がハウジング4aの底部壁42aの中央部に挿入された状態で固着される。また、本発明では、穿刺部21aからハウジング4aの底部壁42aに固着された部分にかけての形状は、必ずしも外径が一様な図8に示したような形状に限定されるものではなく、連続的に外径を変化させた形状としてもよい。   When the drug solution injection needle 1a is a long needle for subcutaneous and intramuscular use, it is not necessary that all the parts that can be punctured in the living body are thinner than the liquid introduction needle part 3a. For example, as shown in FIG. 9, a portion where the outer diameter changes continuously can also be punctured into the living body, and as a result, the outer portion with a constant outer diameter located on the base end side is the bottom wall of the housing 4a. It is fixed in a state where it is inserted into the central portion of 42a. Further, in the present invention, the shape from the puncture portion 21a to the portion fixed to the bottom wall 42a of the housing 4a is not necessarily limited to the shape as shown in FIG. Alternatively, the outer diameter may be changed.

また、本発明では、例えば図10に示すように、穿刺針部2aの基端部が薬液導入針部3aの先端側の開口部に挿入されて両針部2a、3aがあらかじめ固着されてもよい。固着は、接着あるいは溶接などにより行うことができる。そして、あらかじめ相互に固着された穿刺針部2aおよび薬液導入針部3aは、例えば図10に示したような形で、インサート成形、あるいは接着によりハウジング4aに固着される。   In the present invention, for example, as shown in FIG. 10, even if the proximal end portion of the puncture needle portion 2a is inserted into the opening on the distal end side of the drug solution introduction needle portion 3a and the both needle portions 2a and 3a are fixed in advance. Good. Fixing can be performed by adhesion or welding. And the puncture needle part 2a and the chemical | medical solution introduction needle part 3a which were mutually fixed beforehand are fixed to the housing 4a by insert molding or adhesion | attachment in the form as shown, for example in FIG.

また、本発明では、例えば図11に示すように、穿刺針部2aの基端側の端面と薬液導入針部3aの先端側の端面とがあらかじめ固着されてもよい。固着は、接着あるいは溶接などにより行うことができる。この場合、穿刺針部2aと薬液導入針部3aとの接合面の近傍が、薬液導入針部3aから穿刺針部2aの穿刺部21aに向かってその内径が漸減するような形状(テーパ形状)をなすように構成してもよい。これにより、薬液は、液体導入部3aから穿刺部21aへと流れる際にその流速が加速され、勢いよく流れる。   Further, in the present invention, for example, as shown in FIG. 11, the end surface on the proximal end side of the puncture needle portion 2a and the end surface on the distal end side of the drug solution introduction needle portion 3a may be fixed in advance. Fixing can be performed by adhesion or welding. In this case, the shape (tapered shape) where the inner diameter of the vicinity of the joint surface between the puncture needle portion 2a and the drug solution introduction needle portion 3a gradually decreases from the drug solution introduction needle portion 3a toward the puncture portion 21a of the puncture needle portion 2a. You may comprise so that. Thereby, when the chemical liquid flows from the liquid introduction part 3a to the puncture part 21a, the flow velocity is accelerated and flows vigorously.

また、図7〜図11に示す薬液注入針は、1本の穿刺針部2aのみを有しているが、本発明の薬液注入針はこれに限られず、1本の薬液導入針部3aに対し、複数本の穿刺針部2aが対応して設けられていてもよい。また、穿刺針部2aおよび薬液導入針部3aの対が1つのハウジング4aに対し、複数対設けられていてもよい。   Moreover, although the chemical | medical solution injection needle shown in FIGS. 7-11 has only one puncture needle part 2a, the chemical | medical solution injection needle of this invention is not restricted to this, One chemical | medical solution introduction needle part 3a is provided. On the other hand, a plurality of puncture needle portions 2a may be provided correspondingly. A plurality of pairs of puncture needle portion 2a and drug solution introduction needle portion 3a may be provided for one housing 4a.

図12は、本発明の第3の実施形態に係る薬液注入針の側面図、図13は、図12に示される薬液注入針の断面図である。なお、以下においては、上記の第1の実施形態と相違する点を主に説明し、共通する点については適宜説明を省略する。   FIG. 12 is a side view of a chemical liquid injection needle according to the third embodiment of the present invention, and FIG. 13 is a cross-sectional view of the chemical liquid injection needle shown in FIG. In the following, differences from the first embodiment will be mainly described, and description of common points will be omitted as appropriate.

本発明の第3の実施形態に係る薬液注入装置は、第1の実施形態に対し、薬液注入針の構成のみが相違しており、注入器本体5の構成は同じである。   The chemical injection device according to the third embodiment of the present invention is different from the first embodiment only in the configuration of the chemical injection needle, and the configuration of the injector body 5 is the same.

図12および図13に示すように、薬液注入針1bは、生体内に穿刺可能な穿刺部21bを備えた穿刺針部2bと、液体容器51内に連通可能な液体導入針部3bと、これら穿刺針部2bおよび液体導入針部3bの間を薬液が流通可能な状態で当該両針部2b、3bを支持するハウジング4bとを備えている。   As shown in FIGS. 12 and 13, the chemical injection needle 1 b includes a puncture needle portion 2 b having a puncture portion 21 b that can be punctured in a living body, a liquid introduction needle portion 3 b that can communicate with the liquid container 51, and these And a housing 4b that supports the needles 2b and 3b in a state in which a drug solution can flow between the puncture needle 2b and the liquid introduction needle 3b.

図示のように、第3の実施形態に係る薬液注入針1bは、薬液導入針部3bとハウジング4bとが同じ材料により一体的に形成されている点で、穿刺針部2と液体導入針部3とが同じ一つの針体により形成されている第1の実施形態に係る薬液注入針1や、穿刺針部2aと薬液導入針部3aとが別々の独立した針体により形成されている第2の実施形態に係る薬液注入針1aと相違している。   As shown in the figure, the medicinal solution injection needle 1b according to the third embodiment is that the medicinal solution introducing needle portion 3b and the housing 4b are integrally formed of the same material, and thus the puncture needle portion 2 and the liquid introducing needle portion. 3 is formed by a single needle body, and the liquid injection needle 1 according to the first embodiment, and the puncture needle portion 2a and the chemical liquid introduction needle portion 3a are formed by separate independent needle bodies. This is different from the chemical injection needle 1a according to the second embodiment.

ハウジング4bは、円筒部41bと、円筒部41bの一端に形成された底部壁42bとを備えている。円筒部41bの内面には、薬液容器51のボス部53に形成された雄ねじ57に螺合される雌ねじ43bが形成されている。   The housing 4b includes a cylindrical portion 41b and a bottom wall 42b formed at one end of the cylindrical portion 41b. On the inner surface of the cylindrical portion 41b, a female screw 43b that is screwed into a male screw 57 formed on the boss portion 53 of the chemical solution container 51 is formed.

穿刺針部2bは、上述した実施形態の穿刺針部2、2aと同様な材料により作られる中空針から構成されている。この穿刺針部2bは、根元部22bがハウジング4bの底部壁42bの先端側に形成された取付用孔44bに挿入された状態で、ハウジング4bに固着される。   The puncture needle part 2b is comprised from the hollow needle made from the material similar to the puncture needle parts 2 and 2a of embodiment mentioned above. The puncture needle portion 2b is fixed to the housing 4b in a state where the root portion 22b is inserted into a mounting hole 44b formed on the distal end side of the bottom wall 42b of the housing 4b.

液体導入針部3bは、前述したように、ハウジング4bと同じ材料により一体成形加工されることによって、底部壁42bの基端側に形成される。液体導入針部3bおよびハウジング4bの形成に使用される材料は、上述した実施形態のハウジング4、4aと同様な材料である。薬液導入針部3bの基端側の端部には、薬液容器51の先端部に形成された薬液注入口54を封止する弾性部材55を貫くための刃先31bが形成されている。刃先31bは、例えば、液体導入針部3bおよびハウジング4bの成形加工時に同時に形成される。なお、刃先31bは、薬液導入針部3aの端部を斜めにカットすることにより形成してもよい。また、刃先31bの形状は、弾性部材55を貫くために適した形状であればよく、例えば円錐状に尖った形状であってもよい。そして、液体導入針部3bは、穿刺針部2bの穿刺部21bよりも外径が大きく設定される。   As described above, the liquid introduction needle portion 3b is formed on the base end side of the bottom wall 42b by being integrally molded with the same material as the housing 4b. The material used for forming the liquid introduction needle portion 3b and the housing 4b is the same material as the housings 4 and 4a of the above-described embodiment. A blade edge 31b for penetrating an elastic member 55 that seals the chemical solution inlet 54 formed at the distal end portion of the chemical solution container 51 is formed at the proximal end of the chemical solution introduction needle portion 3b. The blade edge 31b is formed at the same time when the liquid introduction needle portion 3b and the housing 4b are formed, for example. The cutting edge 31b may be formed by cutting the end portion of the chemical solution introduction needle portion 3a obliquely. Further, the shape of the blade edge 31b may be any shape that is suitable for penetrating the elastic member 55, and may be, for example, a conical pointed shape. The liquid introduction needle portion 3b is set to have a larger outer diameter than the puncture portion 21b of the puncture needle portion 2b.

ハウジング4bには、穿刺針部2bおよび液体導入針部3bの間を繋ぐための孔46bが形成されている。   The housing 4b is formed with a hole 46b for connecting the puncture needle portion 2b and the liquid introduction needle portion 3b.

第3の実施形態では、薬液導入針部3bの外径は、好ましくは0.3mm以上、2mm以下、より好ましくは0.35mm以上、1.5mm以下である。これに伴って、薬液導入針部3bの内径は、0.25mm以上、1.2mm以下が望ましい。   In 3rd Embodiment, the outer diameter of the chemical | medical solution introduction needle | hook part 3b becomes like this. Preferably they are 0.3 mm or more and 2 mm or less, More preferably, they are 0.35 mm or more and 1.5 mm or less. Accordingly, the inner diameter of the chemical solution introduction needle portion 3b is preferably 0.25 mm or more and 1.2 mm or less.

穿刺針部2bのハウジング4bへの固着は、例えば図13に示したような形で、インサート成形、あるいは接着により行われる。ここで、図13に示すように、薬液導入針部3bがハウジング4bと同じ材料により一体成形加工されているので、薬液注入針1bを特殊な製法を必要とせずに従来と同様な方法で簡便に作ることができる。しかも、穿刺針部2bは、取付用孔44bに係合された状態となるので、ハウジング4bに強固に固着される。   The puncture needle portion 2b is fixed to the housing 4b by, for example, insert molding or adhesion in the form shown in FIG. Here, as shown in FIG. 13, since the chemical solution introduction needle portion 3b is integrally formed from the same material as that of the housing 4b, the chemical solution injection needle 1b can be simply used in the same manner as before without requiring a special manufacturing method. Can be made. Moreover, since the puncture needle portion 2b is engaged with the mounting hole 44b, it is firmly fixed to the housing 4b.

なお、薬液注入針1bが皮下・筋肉内用の長針の場合、生体内に穿刺可能な部分のすべてが液体導入針部3bよりも細くなる必要はない。例えば図14に示すように、外径が連続的に変化する部分もまた生体内に穿刺可能とされ、結果的に、基端側に位置する外径が一定で太い部分がハウジング4bの底部壁42bの中央部に挿入された状態で固着される。また、本発明では、穿刺部21bからハウジング4bの底部壁42bに固着された部分にかけての形状は、必ずしも外径が一様な図13に示したような形状に限定されるものではなく、連続的に外径を変化させた形状としてもよい。   When the drug solution injection needle 1b is a long needle for subcutaneous or intramuscular use, it is not necessary that all the parts that can be punctured in the living body are thinner than the liquid introduction needle part 3b. For example, as shown in FIG. 14, a portion where the outer diameter continuously changes can also be punctured into the living body, and as a result, the outer portion with a constant outer diameter located on the base end side is the bottom wall of the housing 4b. It is fixed in a state where it is inserted into the central portion of 42b. In the present invention, the shape from the puncture portion 21b to the portion fixed to the bottom wall 42b of the housing 4b is not necessarily limited to the shape as shown in FIG. Alternatively, the outer diameter may be changed.

また、本発明では、例えば図15に示すように、薬液導入針部3bの内径を変えずに、外径を刃先31bに向かって漸減するような形状(テーパ形状)に連続的に変化させてもよい。これにより、薬液容器51の先端部に形成された薬液注入口54を封止する弾性部材55に薬液導入針部3bを刺し易くすることができる。   Further, in the present invention, for example, as shown in FIG. 15, the outer diameter is continuously changed to a shape (tapered shape) that gradually decreases toward the cutting edge 31b without changing the inner diameter of the chemical solution introducing needle portion 3b. Also good. Thereby, it is possible to easily pierce the medicinal solution introduction needle portion 3b into the elastic member 55 that seals the medicinal solution injection port 54 formed at the distal end portion of the medicinal solution container 51.

また、本発明では、例えば図16に示すように、薬液導入針部3bの外径を変えずに、内径を刃先31bに向かって漸増するような形状(テーパ形状)に連続的に変化させてもよい。これにより、薬液は、液体導入部3bから穿刺部21bへと流れる際にその流速が加速され、勢いよく流れる。   In the present invention, for example, as shown in FIG. 16, without changing the outer diameter of the chemical solution introducing needle portion 3b, the inner diameter is continuously changed to a shape (tapered shape) that gradually increases toward the cutting edge 31b. Also good. Thereby, when the chemical liquid flows from the liquid introduction part 3b to the puncture part 21b, the flow rate is accelerated and flows vigorously.

また、本発明では、図示はしないが、外径を刃先31bに向かって漸減するような形状(テーパ形状)に連続的に変化させるとともに、内径を刃先31bに向かって漸増するような形状(テーパ形状)に連続的に変化させてもよいことは勿論である。   In the present invention, although not shown, the outer diameter is continuously changed to a shape (tapered shape) that gradually decreases toward the cutting edge 31b, and the inner diameter is gradually increased toward the cutting edge 31b (tapered). Of course, the shape may be continuously changed.

また、図12〜図16に示す薬液注入針は、1本の穿刺針部2bのみを有しているが、本発明の薬液注入針はこれに限られず、1本の薬液導入針部3bに対し、複数本の穿刺針部2bが対応して設けられていてもよい。また、穿刺針部2bおよび薬液導入針部3bの対が1つのハウジング4bに対し、複数対設けられていてもよい。   Moreover, although the chemical | medical solution injection needle shown in FIGS. 12-16 has only one puncture needle part 2b, the chemical | medical solution injection needle of this invention is not restricted to this, One chemical | medical solution introduction needle part 3b is provided. On the other hand, a plurality of puncture needle portions 2b may be provided correspondingly. In addition, a plurality of pairs of puncture needle portion 2b and drug solution introduction needle portion 3b may be provided for one housing 4b.

なお、以上説明した実施形態は、本発明を限定するために記載されたものではなく、本発明の技術的思想内において当業者により種々変更が可能である。   The embodiments described above are not described for limiting the present invention, and various modifications can be made by those skilled in the art within the technical idea of the present invention.

本発明の第1の実施形態に係る薬液注入針が取り付けられた薬液注入装置の断面図である。It is sectional drawing of the chemical injection device with which the chemical injection needle concerning the 1st Embodiment of this invention was attached. 図1に示される注入器本体の断面図である。It is sectional drawing of the injector main body shown by FIG. 図1に示される薬液注入針の側面図である。It is a side view of the chemical injection needle shown in FIG. 図1に示される薬液注入針の断面図である。It is sectional drawing of the chemical | medical solution injection needle shown by FIG. 第1の実施形態に係る薬液注入針の変形例の断面図である。It is sectional drawing of the modification of the chemical | medical solution injection needle which concerns on 1st Embodiment. 第1の実施形態に係る薬液注入針の別の変形例の断面図である。It is sectional drawing of another modification of the chemical | medical solution injection needle which concerns on 1st Embodiment. 本発明の第2の実施形態に係る薬液注入針の側面図である。It is a side view of the chemical injection needle concerning the 2nd embodiment of the present invention. 図7に示される薬液注入針の断面図である。It is sectional drawing of the chemical | medical solution injection needle shown by FIG. 第2の実施形態に係る薬液注入針の変形例の断面図である。It is sectional drawing of the modification of the chemical | medical solution injection needle which concerns on 2nd Embodiment. 第2の実施形態に係る薬液注入針の別の変形例の断面図である。It is sectional drawing of another modification of the chemical | medical solution injection needle which concerns on 2nd Embodiment. 第2の実施形態に係る薬液注入針のさらに別の変形例の断面図である。It is sectional drawing of another modification of the chemical injection needle concerning a 2nd embodiment. 本発明の第3の実施形態に係る薬液注入針の側面図である。It is a side view of the chemical | medical solution injection needle which concerns on the 3rd Embodiment of this invention. 図12に示される薬液注入針の断面図である。It is sectional drawing of the chemical | medical solution injection needle shown by FIG. 第3の実施形態に係る薬液注入針の変形例の断面図である。It is sectional drawing of the modification of the chemical | medical solution injection needle which concerns on 3rd Embodiment. 第3の実施形態に係る薬液注入針の別の変形例の断面図である。It is sectional drawing of another modification of the chemical | medical solution injection needle which concerns on 3rd Embodiment. 第3の実施形態に係る薬液注入針のさらに別の変形例の断面図である。It is sectional drawing of another modification of the chemical injection needle concerning a 3rd embodiment. 従来の薬液注入針の側面図である。It is a side view of the conventional chemical injection needle. 従来の薬液注入針の断面図である。It is sectional drawing of the conventional chemical | medical solution injection needle.

符号の説明Explanation of symbols

1,1a,1b…薬液注入針(液体注入針)、
2,2a,2b…穿刺針部、
21,21a,21b…穿刺部、
22…中間部、
3,3a,3b…薬液導入針部(液体導入針部)、
31,31a,31b…刃先、
4,4a,4b…ハウジング(基体部)、
5…注入器本体、
51…薬液容器(液体容器)、
54…薬液注入口(液体注入口)、
55…弾性部材、
60…薬液(液体)。
1, 1a, 1b ... chemical injection needle (liquid injection needle),
2, 2a, 2b ... puncture needle part,
21, 21a, 21b ... puncture part,
22 ... middle part,
3, 3a, 3b ... chemical introduction needle (liquid introduction needle),
31, 31a, 31b ... cutting edge,
4, 4a, 4b ... housing (base part),
5 ... injector body,
51 ... Chemical container (liquid container),
54 ... Chemical solution inlet (liquid inlet),
55 ... an elastic member,
60: Chemical solution (liquid).

Claims (3)

内部に液体が収容される液体容器の先端部に形成された液体注入口に取り付けられる液体注入針であって、
生体内に穿刺可能な穿刺部を備えた穿刺針部と、
前記液体容器内に連通可能な液体導入針部と、
前記穿刺針部および前記液体導入針部間を液体が流通可能な状態で当該両針部を支持する基体部とを有し、
前記液体導入針部は、前記穿刺部の少なくとも先端近傍よりも外径が大きく、
前記液体導入針部の端部に、前記液体容器の液体注入口を封止する弾性部材を貫くための刃先が形成されており、
前記穿刺針部と前記液体導入針部とは、同じ一つの針体により形成されており、
前記穿刺針部は、前記穿刺部と前記液体導入針部との間に形成され外径が連続的に変化して両者を滑らかに繋ぐ中間部を有し、
前記穿刺部の外径は0.1mm以上0.254mm以下、前記穿刺部の内径は0.05mm以上0.15mm以下である
ことを特徴とする液体注入針。
A liquid injection needle attached to a liquid injection port formed at the tip of a liquid container in which liquid is stored,
A puncture needle portion having a puncture portion capable of being punctured in a living body,
A liquid introduction needle portion capable of communicating with the liquid container;
A base portion that supports both needle portions in a state in which liquid can flow between the puncture needle portion and the liquid introduction needle portion;
The liquid introduction needle part has an outer diameter larger than at least the tip vicinity of the puncture part,
A blade edge for penetrating an elastic member that seals the liquid inlet of the liquid container is formed at the end of the liquid introduction needle part,
The puncture needle portion and the liquid introduction needle portion are formed by the same single needle body,
The puncture needle portion has an intermediate portion that is formed between the puncture portion and the liquid introduction needle portion, and the outer diameter continuously changes to smoothly connect the two.
An outer diameter of the puncture portion is 0.1 mm or more and 0.254 mm or less, and an inner diameter of the puncture portion is 0.05 mm or more and 0.15 mm or less.
前記穿刺針部のうち基体部の底部壁から外方へ突出した部分の長さは、0.5mm以上10mm以下であることを特徴とする請求項1に記載の液体注入針。   2. The liquid injection needle according to claim 1, wherein a length of a portion of the puncture needle portion that protrudes outward from a bottom wall of the base portion is not less than 0.5 mm and not more than 10 mm. 先端部に液体注入口が形成され内部に液体が収容される液体容器と、前記液体容器の液体注入口に取り付けられる請求項1または2に記載の液体注入針とを有することを特徴とする液体注入装置。   3. A liquid comprising: a liquid container having a liquid inlet formed at a tip thereof and containing a liquid therein; and the liquid injection needle according to claim 1 attached to the liquid inlet of the liquid container. Injection device.
JP2007203468A 2000-09-14 2007-08-03 Liquid injection needle and liquid injector Pending JP2007283132A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007203468A JP2007283132A (en) 2000-09-14 2007-08-03 Liquid injection needle and liquid injector

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000280361 2000-09-14
JP2007203468A JP2007283132A (en) 2000-09-14 2007-08-03 Liquid injection needle and liquid injector

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000389248A Division JP4187922B2 (en) 2000-09-14 2000-12-21 Liquid injection needle and liquid injection device

Publications (1)

Publication Number Publication Date
JP2007283132A true JP2007283132A (en) 2007-11-01

Family

ID=38755398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007203468A Pending JP2007283132A (en) 2000-09-14 2007-08-03 Liquid injection needle and liquid injector

Country Status (1)

Country Link
JP (1) JP2007283132A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009092084A1 (en) 2008-01-17 2009-07-23 Becton, Dickinson And Company Drug delivery device for drug suspensions
EP2338551A2 (en) * 2008-06-06 2011-06-29 Wockhardt Limited A device and a system for delivery of biological material
WO2013027799A1 (en) * 2011-08-24 2013-02-28 テルモ株式会社 Injection needle
WO2015037233A1 (en) * 2013-09-11 2015-03-19 テルモ株式会社 Medical hollow needle assembly and method for manufacturing hollow needle
JP2015510798A (en) * 2012-03-16 2015-04-13 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Drug delivery device for drug suspension
CN111685856A (en) * 2020-05-25 2020-09-22 青岛大学附属医院 Double-drill-bit minimally invasive puncture instrument kit for DRG injection

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2187259A (en) * 1936-07-11 1940-01-16 George E Barnhart Hypodermic needle
JPS57113149U (en) * 1980-12-29 1982-07-13
US4643199A (en) * 1986-02-28 1987-02-17 Jennings Jr Baldwin P Safety blood sample apparatus
US4944677A (en) * 1987-06-29 1990-07-31 Raymond Joseph Alexandre Intraosseus dental anesthesia apparatus and method
JPH06503025A (en) * 1991-03-29 1994-04-07 コラーゲン コーポレイション Device and method for treating facial wrinkles
JPH06508772A (en) * 1991-05-22 1994-10-06 パーキン エードリアン hypodermic needle
WO1997039787A1 (en) * 1996-04-24 1997-10-30 Novo Nordisk A/S Injection needle
US5688246A (en) * 1991-04-19 1997-11-18 Biotime, Inc. Microcannula
JPH10113390A (en) * 1996-09-26 1998-05-06 Becton Dickinson & Co Medicine administering pen having 31-gauge needle
JP2000024106A (en) * 1998-07-14 2000-01-25 Shimadzu Corp Injector

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2187259A (en) * 1936-07-11 1940-01-16 George E Barnhart Hypodermic needle
JPS57113149U (en) * 1980-12-29 1982-07-13
US4643199A (en) * 1986-02-28 1987-02-17 Jennings Jr Baldwin P Safety blood sample apparatus
US4944677A (en) * 1987-06-29 1990-07-31 Raymond Joseph Alexandre Intraosseus dental anesthesia apparatus and method
JPH06503025A (en) * 1991-03-29 1994-04-07 コラーゲン コーポレイション Device and method for treating facial wrinkles
US5688246A (en) * 1991-04-19 1997-11-18 Biotime, Inc. Microcannula
JPH06508772A (en) * 1991-05-22 1994-10-06 パーキン エードリアン hypodermic needle
WO1997039787A1 (en) * 1996-04-24 1997-10-30 Novo Nordisk A/S Injection needle
JPH10113390A (en) * 1996-09-26 1998-05-06 Becton Dickinson & Co Medicine administering pen having 31-gauge needle
JP2000024106A (en) * 1998-07-14 2000-01-25 Shimadzu Corp Injector

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10463810B2 (en) 2008-01-17 2019-11-05 Becton, Dickinson And Company Drug delivery device for drug suspensions
JP2011509765A (en) * 2008-01-17 2011-03-31 ベクトン・ディキンソン・アンド・カンパニー Drug delivery device for drug suspension
WO2009092084A1 (en) 2008-01-17 2009-07-23 Becton, Dickinson And Company Drug delivery device for drug suspensions
US11547810B2 (en) 2008-01-17 2023-01-10 Becton, Dickinson And Company Drug delivery device for drug suspensions
EP2338551A2 (en) * 2008-06-06 2011-06-29 Wockhardt Limited A device and a system for delivery of biological material
WO2013027799A1 (en) * 2011-08-24 2013-02-28 テルモ株式会社 Injection needle
US10207053B2 (en) 2012-03-16 2019-02-19 Becton, Dickinson And Company Drug delivery device for drug suspensions
JP2015510798A (en) * 2012-03-16 2015-04-13 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Drug delivery device for drug suspension
US11452816B2 (en) 2012-03-16 2022-09-27 Becton, Dickinson And Company Drug delivery device for drug suspensions
JPWO2015037233A1 (en) * 2013-09-11 2017-03-02 テルモ株式会社 Hollow needle assembly for medical use and method for manufacturing hollow needle
US10434265B2 (en) 2013-09-11 2019-10-08 Terumo Kabushiki Kaisha Medical hollow needle assembly and method of manufacturing hollow needle
WO2015037233A1 (en) * 2013-09-11 2015-03-19 テルモ株式会社 Medical hollow needle assembly and method for manufacturing hollow needle
CN111685856A (en) * 2020-05-25 2020-09-22 青岛大学附属医院 Double-drill-bit minimally invasive puncture instrument kit for DRG injection
CN111685856B (en) * 2020-05-25 2023-09-22 青岛大学附属医院 Double-drill minimally invasive puncture instrument suite for DRG injection

Similar Documents

Publication Publication Date Title
JP4187922B2 (en) Liquid injection needle and liquid injection device
JP4083425B2 (en) Liquid injection needle and liquid injection device
JP4286897B2 (en) Ampoule that can be used as a syringe, and syringe unit
RU2288746C2 (en) Needle cannula and method for producing and using the needle cannula
JP2007283132A (en) Liquid injection needle and liquid injector
JP2019088812A (en) Anesthesia applicators/injectors for dental and other applications and methods of use
JP2014513558A (en) Transdermal administration device and needle forming body used in the device
JP4153736B2 (en) Needle
US8622977B2 (en) Carrier for injecting a product into the human body
JP2008200528A (en) Injection needle
JP2011212183A (en) Prefilled syringe
KR20040007850A (en) Needle socket for a blood vessel injection
JPH0331305Y2 (en)
CN213698354U (en) Insulin injection pen needle head not prone to needle breakage
JP6068057B2 (en) Transdermal dosing device and chemical injection needle used in the device
KR20070062002A (en) Needle for dental treatment
RU2180860C1 (en) Carpula
CN113423446A (en) Indwelling needle for subcutaneous administration
JP2017051408A (en) Medicine subcutaneous infusion system

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071217

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100706

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100921

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110222